A study found that tumor-derived exosomal miR-183-5p up-regulates PD-L1-expressing macrophages to foster immune suppression and disease progression in ICC through the miR-183-5p/PTEN/AKT/PD-L1 pathway [44]. The gene discussed is AKT1; the disease is intrahepatic cholangiocarcinoma.